-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-maternal-health-grand-rounds-slides.pptx
January 01, 2023 - based on evidence that is generally accepted within the profession as adequate justification for their indications
-
effectivehealthcare.ahrq.gov/sites/default/files/selecting-evidence-quiz.ppt
May 29, 2025 - Quantitative Synthesis II: Interactive Quiz
When To Select Observational Studies
Interactive Quiz
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
When To Select Observational Studies Interactive Quiz
When should observational …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence-quiz.ppt
May 29, 2025 - Quantitative Synthesis II: Interactive Quiz
When To Select Observational Studies
Interactive Quiz
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
When To Select Observational Studies Interactive Quiz
When should observational …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
April 25, 2013 - period (noted on page 96 of
the report) and application of that assumed rate across the broad
range of indications … interpreted correctly, the relative impact of ESAs
on on-study mortality is assumed to be level across all indications … disease, it may not be appropriate to assume the same relative
impact (risk) of ESA use across all indications … We have noted now more clearly in the text
differences in use in the included trials and current
indications
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
September 13, 2013 - Vitamin-D-Calcium-Protocol-130611
Source: www.effectivehealthcare.ahrq.gov
Published online: June 10, 2013
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Vitamin D and Calcium: A Systematic Review of
Health Outcomes
I. Background and Objectives for the Systematic R…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-protein-intake-disposition-comments.pdf
November 22, 2024 - Disposition of Comments_Systematic Review_The Effect of Protein Intake on Health: A Systematic Review
Systematic Review Disposition of Comments Report
Title: The Effect of Protein Intake on Health: A Systematic Review
Draft report available for public comment from May 1, 2024, to May 31, 2024.
Citation: Lamina …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis-future_research_1.pdf
February 01, 2013 - review of the evidence, potentially followed
by national or broad registry for imaging for common indications … mainly from
current administrative
datasets have
limitations
Yes: if patient level
data with indications … comorbidities
are captured
Yes: this is feasible
with a NIT registry or
cohort of patients with
similar indications … observational
studies across broad
studies
Yes: national or broad
registry for imaging for
common indications … review of the evidence, potentially
followed by national or broad registry for imaging for common indications
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-tools_research-protocol.pdf
April 14, 2016 - palliative-care-protocol
Evidence-based Practice Center
Technical Brief Protocol
Project Title: Assessment Tools for Palli…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dyspnea_research.pdf
April 01, 2010 - Dyspnea DEcIDE
The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of
AHRQ’s Effective Health Care Program. It is a collaborative network of research centers that
support the rapid development of new scientific information and analytic tools. The DEcIDE
network assists healt…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
May 09, 2016 - will not include
statins and antihypertensives in this review, because they are prescribed for other indications … neuropathy (e.g. gabapentin, lidocaine patches for herpes zoster),
but most are approved for other indications
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-imaging_disposition-comments.pdf
October 01, 2014 - groups have developed appropriate
use criteria and practice guidelines specific to individual clinical
indications … and evidence, and aid physicians to determine the
appropriate scans to be used for specific clinical indications
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
March 13, 2012 - for
ovarian cancer, by virtue of having at least one ovary, can use OCs for contraception or other
indications … Because OCs may
affect the risk of these other indications, they may indirectly affect ovarian cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_surveillance.pdf
May 01, 2013 - nonsignificant to significant)
B2 A change in relative effect size of at least 50 percent
RAND Method Indications
-
effectivehealthcare.ahrq.gov/sites/default/files/study-design-considerations-chapter-2.pptx
January 01, 2013 - Indications for propensity scores and review of their use in pharmacoepidemiology.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ocr-protocol-final_1.pdf
December 18, 2019 - approximately one-quarter of
term pregnancies, with estimates of 77 to 85 percent occurring due to medical indications … Induction of labor in the absence of
standard medical indications: incidence and
correlates.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-263-postpartum-hypertensive-pregnancy-executive-summary.pdf
May 01, 2023 - administered with MgSO4.
7
Overall, the evidence base remains incomplete regarding the indications
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-ki-tep-confidentiality-form.pdf
August 01, 2020 - Disclosure Policy and Form
EPC Key Informant and Technical Expert Agreement
The primary role of the Key Informant is to provide input on proposed review questions to help
the EPC ensure that a resulting evidence review will be useful for people making real-world
decisions.
The primary role of the Technical…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
March 10, 2010 - rosuvastatin” (from PI)
Under PK column: add “minimally” to “metabolized by CYP 450-2C9”
Under Labeled Indications … adult patients as part of a treatment strategy to lower
TC and LDL-C to target levels”
Under Labeled Indications … which fluvastatin is metabolized by each isozyme: 2C9 (75%), 2C8
(~5%), 3A4 (~20%)
- Under labeled indications
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
July 01, 2014 - Antidepressant medications are used to treat a variety
of other indications, including anxiety disorders … evidence suggested greater risk
of neonatal withdrawal symptoms with fluoxetine use for
any reason (indications … drawback is that we do not know
the differential baseline risk of various outcomes for the
various indications
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
March 01, 2013 - applicable to interventions for abnormal bleeding is a
challenge because many agents have multiple indications … information from existing contemporary
reviews and guidance on harms for common
medications with broad indications … majority are not
recognized at the time of insertion.94-97 Nulliparous
status and noncontraceptive indications